New study aims to predict which patients benefit from targeted radiation therapy
NCT ID NCT06256705
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 21 times
Summary
This study will follow 80 people with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who are receiving peptide receptor radionuclide therapy (PRRT). Researchers will use advanced PET-MRI scans and genetic profiling before, during, and after treatment to find patterns that predict how well the therapy works. The goal is to improve patient selection and treatment effectiveness, not to test a new drug or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hépato-gastro-entérologie, cancérologie digestive et assistance nutritionnelle - CHU Nantes
ACTIVE_NOT_RECRUITINGNantes, 44000, France
-
Médecine nucléaire - CHU Nantes
RECRUITINGNantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine nucléaire et Biophysique - Beaujon
RECRUITINGClichy, 92110, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Pancréatologie et Oncologie Digestive - Beaujon
RECRUITINGClichy, 92110, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Service de Médecine Nucléaire, Groupe Hospitalier Bichat-Claude Bernard
ACTIVE_NOT_RECRUITINGParis, 75018, France
Conditions
Explore the condition pages connected to this study.